Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. (Q39957913)

15 September 2017

Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. (English)

1 reference

15 September 2017

6

Ulrike Kammerer

1 reference

15 September 2017

Melanie Schmidt

1

1 reference

15 September 2017

Hans-Ullrich Voelker

2

1 reference

15 September 2017

Michaela Kapp

3

1 reference

15 September 2017

Mathias Krockenberger

4

1 reference

15 September 2017

Johannes Dietl

5

1 reference

15 September 2017

language of work or name

1 reference

5 August 2009

1 reference

Journal of Cancer Research and Clinical Oncology

15 September 2017

1 reference

15 September 2017

136

1 reference

15 September 2017

219-225

1 reference

15 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-009-0652-y

15 September 2017

0 references

cites work

AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0652-Y

Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted

21 January 2018

1 reference

12 December 2020

Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual

1 reference

12 December 2020

Glucose metabolism and angiogenesis in granulosa cell tumors of the ovary: activation of Akt, expression of M2PK, TKTL1 and VEGF.

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

The human myoepithelial cell is a natural tumor suppressor

1 reference

12 December 2020

Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival

1 reference

12 December 2020

[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]

1 reference

12 December 2020

Tumor M2-pyruvate kinase in the follow-up of inoperable lung cancer patients: a pilot study

1 reference

12 December 2020

Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases

1 reference

12 December 2020

Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose.

1 reference

12 December 2020

Pyruvate kinase type M2 and its role in tumor growth and spreading

1 reference

12 December 2020

Chronic myeloid leukaemia: an investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation.

1 reference

12 December 2020

The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study

1 reference

12 December 2020

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

1 reference

12 December 2020

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation

1 reference

12 December 2020

Glycolysis inhibition for anticancer treatment

1 reference

12 December 2020

Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTestTM in breast carcinoma by image analysis.

1 reference

12 December 2020

Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer

1 reference

12 December 2020

10.1007/S00432-009-0652-Y

Identifiers

DOI

1 reference

15 September 2017

1 reference